Russell Bird - REMSleep Holdings CEO and President and Director

All Insiders . USA . 
Stock . REMSleep Holdings . Stakeholders . Insider . Russell Bird
RMSL Stock  USD 0.01  0.0001  1.56%   

CEO

Russell Bird is CEO and President and Director of REMSleep Holdings
Age 74
Phone813 367 3855
Webhttps://www.remsleeptech.com

REMSleep Holdings Management Efficiency

The company has return on total asset (ROA) of (0.1839) % which means that it has lost $0.1839 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5467) %, meaning that it created substantial loss on money invested by shareholders. REMSleep Holdings' management efficiency ratios could be used to measure how well REMSleep Holdings manages its routine affairs as well as how well it operates its assets and liabilities.
REMSleep Holdings currently holds 512.03 K in liabilities with Debt to Equity (D/E) ratio of 0.15, which may suggest the company is not taking enough advantage from borrowing. REMSleep Holdings has a current ratio of 7.91, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist REMSleep Holdings until it has trouble settling it off, either with new capital or with free cash flow. So, REMSleep Holdings' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like REMSleep Holdings sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for REMSleep to invest in growth at high rates of return. When we think about REMSleep Holdings' use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 6 records

CEO Age

Nicholas CurtisLENSAR Inc
68
Nestor JaramilloNuwellis
67
Robert FordAbbott Laboratories
50
Karen ZaderejAxogen Inc
62
Steven FosterTenon Medical
56
Charles IIApyx Medical
58
REMSleep Holdings, Inc. focuses on the development and distribution of products to help people affected by sleep apnea worldwide. It serves home care dealers, private sleep labs, product end users, physicians, medical group, and hospitals, as well as medical associations. Remsleep Holdings operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 2 people. REMSleep Holdings [RMSL] is traded as part of a regulated electronic over-the-counter service offered by the NASD.

Management Performance

Return On Equity-0.55
Return On Asset-0.18

REMSleep Holdings Management Team

Elected by the shareholders, the REMSleep Holdings' board of directors comprises two types of representatives: REMSleep Holdings inside directors who are chosen from within the company, and outside directors, selected externally and held independent of REMSleep. The board's role is to monitor REMSleep Holdings' management team and ensure that shareholders' interests are well served. REMSleep Holdings' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, REMSleep Holdings' outside directors are responsible for providing unbiased perspectives on the board's policies.
Jonathan Lane, Chief Engineer and Director
Russell Bird, CEO and President and Director
Thomas Wood, CEO, Founder

REMSleep Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is REMSleep Holdings a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity-0.55
Return On Asset-0.18
Operating Margin(3.58) %
Current Valuation17.17 M
Shares Outstanding1.46 B
Shares Owned By Insiders3.63 %
Shares Owned By Institutions0.04 %
Price To Earning(2.93) X
Price To Book6.04 X
Price To Sales72.16 X

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Other Information on Investing in REMSleep OTC Stock

REMSleep Holdings financial ratios help investors to determine whether REMSleep OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in REMSleep with respect to the benefits of owning REMSleep Holdings security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY